• Home
  • » 
  • Reports
  • » 
  • Elastomeric Closure Components Market Fo...

pharmaceutical closures

Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures

  • Lowest Price Guaranteed From USD 4,499

  • Published
    May 2019

  • Pages
    407

  • View Count
    19282

  • Buy Now

Example Insights

Elastomeric-Closure-Components-Market-for-Vials-Context-thumb Elastomeric-Closure-Components-Market-for-Vials-Parenteral-Containers-thumb Elastomeric-Closure-Components-Market-for-Vials-Elastomeric-Material-thumb
Elastomeric-Closure-Components-Market-for-Vials-Trends-Analysis-thumb Elastomeric-Closure-Components-Market-for-Vials-Conference-Agendas-thumb Elastomeric-Closure-Components-Market-for-Vials-Pharmaceutical-Packaging-thumb
Elastomeric-Closure-Components-Market-for-Vials-Global-Demand-thumb Elastomeric-Closure-Components-Market-for-Vials-Closures-Market-thumb  

Report Description

One of the main reasons for choosing elastomeric materials for manufacturing closures is their anti-leaching property and limited interaction potential of the material with the formulation present in vial / syringe. Further, using ready-to-use products saves a lot of time and effort in the overall production processes

-- Project Manager, Business Development, a US based mid-sized company

The global elastomeric closures market is likely to increase from $4.6 billion to $9.3 billion by 2030, growing at a CAGR of 6.7%. Pharmaceutical packaging plays a crucial role in ensuring the sterility and quality of a drug product, while also providing information related to its identity and, in certain cases, dosing instructions. Primary packaging material, owing to the fact that it is in immediate contact with the drug / therapy formulation, is considered to be extremely important when it comes to preserving the stability, efficacy and safety of the packaged drug product. Further, given the growing complexity of modern pharmacological interventions, especially biologics, it has become imperative for drug / therapy packaging considerations to be re-evaluated, taking into consideration the evident shift from large batches of one remedy for everyone to smaller batches of more personalized therapeutic solutions. In addition to optimizing drug-packaging compatibility, stakeholders in the pharmaceutical packaging industry have also adopted a number of other flexible solutions to reduce the overall cost and expedite time to market. 

The use of elastomeric materials, along with various types of coatings (such as FluoroTec® and Teflon®), has emerged as a promising alternative to conventional, non-coated closures used for primary packaging containers, which were prone to leaching and shedding of particulate contaminants. The advantages of using elastomeric materials in manufacturing container closures are many, including low leaching potential, minimal chemical interaction with the pharmacological formulation, and the fact that they can be used to make waterproof and airtight closures. Moreover, such closures can also be manufactured in the ready-to-use (RTU) format, which saves a significant amount of time by eliminating the need for multiple steps in the overall fill / finish process. Owing to the aforementioned benefits, the industry has witnessed an evident growth in preference for elastomeric container closures. 

Scope of the Report

The ‘Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures’ report features a comprehensive study of the current scenario and future potential of the elastomeric, primary packaging closure market. It features an in-depth analysis, highlighting the various types of elastomeric closures including stoppers, needle shields and plungers, available in the market for various types of primary packaging containers, such as cartridges, syringes and vials. In addition to other elements, the study includes: 

  • A detailed assessment of the current market landscape of companies manufacturing elastomeric container closures, featuring information on the type of closure (cap, needle shield, plunger, seal, stopper, and tip cap), type of respective primary container(s) (vial, syringe, and cartridge), elastomeric material(s) used for fabricating the aforementioned closures (such as bromobutyl, chlorobutyl, and others), drug type(s) that are compatible with elastomeric closures, sterilization status of closures (pre-sterilized and unsterilized), affiliated sterilization technique (if the closure(s) is available in the pre-sterilized format), scale of production (small scale, and large scale), type of customization (if available), affiliated dimensions, along with compliance certifications of the product. 
  • A comprehensive analysis on the packaging trends of over 230 drug products (including both biologics and small molecule drugs) that were approved over the last five years (beginning 2014), featuring an assessment of the packaging requirements of various container-closure systems based on parameters, such as year of approval of drug, type of molecule, dosage form, route of administration, holding temperature, type of packaging material(s) used for manufacturing primary container and affiliated closure, and leading drug developers (in terms of number of drugs packaged using elastomeric closures). 
  • An analysis of various developments / recent trends related to elastomeric packaging materials, offering insights on [A] partnerships and collaborations established within the industry, and [B] recent global conferences related to pharmaceutical packaging industry.
  • Elaborate profiles of key players in this domain (shortlisted on the basis of size of product portfolio), featuring a brief overview of the company (including information on company headquarters, year of establishment, number of employees, and key members of the executive team), financial information (if available), detailed description of proprietary elastomeric closures, recent developments, and an informed future outlook.
  • A case study on the role of robotics in pharmaceutical manufacturing and fill / finish operations, highlighting the advantages of using automation / automated technologies in such processes. It includes profiles of industry players offering such equipment for the aseptic processing of pharmaceutical products. 
  • An elaborate discussion on emerging trends (such as focus on personalized therapies, shift towards more flexible packaging, upgrading packaging components to enhance drug product safety, and growing adoption of smart packaging solutions) that are likely to have an impact on the future adoption of elastomeric container-closure components in the pharmaceutical packaging industry. It also features a Harvey ball analysis, highlighting the relative effect of each trend on the overall pharmaceutical packaging industry.
  • An in-depth analysis to estimate the current and future demand for elastomeric closures across key primary packaging containers, including vials, syringes and cartridges, in different regions for the period 2019-2030. Input parameters considered for this analysis include current supply of different primary packaging components and their respective closures and the estimated the proportion of elastomeric closures that are likely to be supplied, which is indicative of the demand. 
  • One of the key objectives of the report was to estimate the existing market size and identify potential growth opportunities for elastomeric closures over the coming decade. Based on several parameters, such as target consumer segments, region specific adoption rates and expected prices of such products, we have provided an informed estimate on the likely evolution of the market over the period 2019-2030. The report provides sales forecasts for the overall elastomeric closure market, wherein both the current and upcoming opportunity is segmented across [A] type of packaging container(s) (vials, syringes and cartridges), [B] type of closure(s) used (seal, stopper, cap, plunger, barrel, and needle shield), [C] sterilization status (pre-sterilized and unsterilized), and [D] key geographies (North America, Europe, Asia-Pacific, and Rest of the World). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

The opinions and insights presented in this study were also influenced by discussions conducted with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals (in alphabetical order of company names): 

  • Julien Maréchal (Business Development and Technology Director, Aseptic Technologies)
  • Malcolm Gilmore (Facilitator, BioPhorum Operations Group)
  • Marco Pederiva (Marketing and Sales Director, Lonstroff)
  • Konstantin Kazarian (Project Manager of Business Development, PYRAMID Laboratories)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Contents

Chapter Outlines

Chapter 2 provides an executive summary of the insights captured during our research. It offers a high-level view on the current state of the market of elastomeric closures and its likely evolution in the short-mid term and long term.

Chapter 3 provides an overview of conventional pharmaceutical packaging and the limitations associated with the currently used container-closure systems. The chapter also lays emphasis on innovation in the pharmaceutical packaging industry and the consequent growth of flexible fill / finish solutions. It features an elaborate discussion on the different considerations for choosing a suitable material for fabricating container-closure systems. Further, the chapter includes a detailed discussion on elastomeric materials, highlighting their properties, and applications across various industries. In addition, it provides an overview of regulatory guidelines associated with elastomeric container-closure systems. It elaborates on the various tests that are necessary to assess and control the quality of elastomeric closures. It concludes with a brief discussion on the advantages and limitations of elastomeric closures, highlighting the growing importance of coated elastomeric materials.

Chapter 4 provides a comprehensive review of the current market landscape of nearly 100 elastomeric closures. It includes a detailed analysis of the aforementioned products based on the type of closure (cap, needle shield, plunger, seal, stopper, and tip cap), type of respective primary container(s) (vial, syringe, and cartridge), elastomeric material(s) used for fabricating the aforementioned closures (such as bromobutyl, chlorobutyl, and others), drug type(s) that are compatible with elastomeric closures, sterilization status of closures (pre-sterilized and unsterilized), affiliated sterilization technique (if closure(s) is available in the pre-sterilized format), scale of production (small scale, and large scale), type of customization (if available), affiliated dimensions, along with compliance certifications of the product. It also provides details of the manufacturer companies, such as year of establishment, company size, and location of headquarters. 

Chapter 5 features detailed profiles of key players (shortlisted on the basis of size of product portfolio) that are involved in fabricating and supplying elastomeric closures. Each company profile features a brief overview of the company (including information on company headquarters, year of establishment, number of employees, and key members of executive team), financial information (if available), detailed descriptions of proprietary elastomeric closures, recent developments and an informed future outlook.

Chapter 6 features packaging trends of over 230 drugs products (including both biologics and small molecule drugs) that were approved over the last five years (beginning 2014). The chapter comprises of in-depth analyses, highlighting the packaging requirements of various container-closure systems based on several parameters, including year of approval of drug, type of molecule, dosage form, route of administration, holding temperature, type of packaging material(s) used for manufacturing primary container and affiliated closure. Furthermore, we have highlighted the leading players in this domain, based on the number of approved drugs packaged using elastomeric closures in the given time period.

Chapter 7 features a detailed assessment of various developments / recent trends related to elastomeric packaging materials. The analysis presented in this chapter offers insights on [A] recent partnerships and collaborations that have been established in the last decade, featuring a comprehensive set of analyses, based on various parameters, such as the year of establishment and headquarters of each company, type of partnership, purpose of collaboration, and type of product, and [B] recent global conferences related to pharmaceutical packaging industry, featuring a set of analyses based on various parameters, such as year, location, and agenda of the conference.

Chapter 8 provides an overview of the current and future demand for elastomeric closures for key primary packaging containers, including vials, syringes and cartridges, in the contemporary market. In order to estimate the aforementioned demand, we considered the current supply of different primary packaging components and their respective closures and estimated the proportion of elastomeric closures that are likely to be supplied to the pharmaceutical industry. We also estimated the likely adoption of such products across geographical regions, over the period 2019-2030. 

Chapter 9 presents a comprehensive market forecast analysis, highlighting the future potential of the market till 2030, based on multiple parameters, such as current demand for respective packaging components, likely adoption rates and the estimated price of components. It includes future sales projections of various closures of key packaging containers. We have segregated the current and upcoming opportunity on the basis of [A] type of packaging container(s) (vials, syringes and cartridges), [B] type of packaging closure(s) (seal, stopper, cap, plunger, barrel, and needle shield), [C] sterilization status (pre-sterilized and unsterilized), and [D] key geographies (North America, Europe and, Asia-Pacific and Rest of the World). It is worth mentioning that we adopted a bottom-up approach for this analysis, backing our claims with relevant datapoints and credible inputs from primary research.

Chapter 10 presents an elaborate case study on the role of robots in the pharmaceutical manufacturing and fill / finish process. It features a list of the various types of pharmaceutical robots, along with details on their respective manufacturer(s) and applications. Further, the chapter includes profiles of players that offer robotic machinery for pharmaceutical manufacturing and fill / finish operations, along with information on the key specifications of such products.  

Chapter 11 discusses key trends in the overall pharmaceutical manufacturing industry. Specifically, it elaborates on the emerging focus on personalized therapies, shift towards more flexible packaging, development of modular facilities, upgrading packaging components to enhance drug product safety, increase in partnership activity, and growing adoption of smart packaging solutions, among others. 

Chapter 12 is a collection of interview transcripts of discussions held with key stakeholders in this market. In this chapter, we have presented the details of interviews held with (in alphabetical order of company names) Julien Maréchal (Business Development and Technology Director, Aseptic Technologies), Malcolm Gilmore (Facilitator, BioPhorum Operations Group), Marco Pederiva (Marketing and Sales Director, Lonstroff), and Konstantin Kazarian (Project manager of Business Development Project Manager, PYRAMID Laboratories).

Chapter 13 is an appendix, which provides tabulated data and numbers for all the figures included in the report.

Chapter 14 is an appendix, which provides the list of companies and organizations mentioned in this report.

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Pharmaceutical Packaging
3.2.1. Types of Pharmaceutical Packaging
3.2.2. Innovation in Pharmaceutical Packaging
3.2.3. Traditional Aseptic Pharmaceutical Filling Operations
3.2.4. Limitations of Traditional Primary Packaging

3.3. Role of Containers-Closures Systems in Pharmaceutical Packaging
3.4. Types of Closures Used in Pharmaceutical Packaging
3.4.1. Closures for Syringes
3.4.2. Closures for Vials
3.4.3. Closures for Cartridges
3.5. Key Considerations for Choosing Materials for Fabricating Closures

3.6. Elastomeric Packaging Materials
3.6.1. Key Properties of Elastomeric Packaging Materials
3.6.2. Popular Types of Elastomeric Packaging Materials
3.6.3. Regulatory Guidelines for Elastomeric Closures
3.6.4. Manufacturing Process for Elastomeric Closures
3.6.5. Quality Assessment Tests for Elastomeric Closures
3.6.6. Advantages and Limitations of Elastomeric Packaging Materials

3.7. Concluding Remarks

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Elastomeric Closures for Parenteral Containers: List of Products
4.2.1. Analysis by Type of Closure
4.2.2. Analysis by Type of Container
4.2.3. Analysis by Type of Elastomeric Material
4.2.4. Analysis by Type of Coating
4.2.5. Analysis by Drug Class
4.2.6. Analysis by Sterilization Status
4.2.7. Analysis by Sterilization Technique

4.3. Elastomeric Closures for Parenteral Containers: List of Manufacturers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Scale of Production
4.3.4. Analysis by Location of Headquarters
4.3.5. Leading Manufacturers: Analysis by Number of Products
4.3.6. Manufacturer Landscape: Analysis by Company Size and Location of Headquarters

4.5. Elastomeric Closures for Parenteral Containers: Recent Initiatives of Players
4.5.1. List of Ready-to-Use Containers-Closure Systems
4.6. Concluding Remarks

5. COMPANY PROFILES
5.1. Chapter Overview
5.2. Key Players Based in North America
5.2.1. Aptar Pharma (a Part of AptarGroup)
5.2.1.1. Company Overview
5.2.1.2. Financial Information
5.2.1.3. Product Portfolio
5.2.1.4. Recent Developments and Future Outlook

5.2.2. DWK Life Sciences
5.2.2.1. Company Overview
5.2.2.2. Product Portfolio
5.2.2.3. Recent Developments and Future Outlook

5.2.3. West Pharmaceutical Services
5.2.3.1. Company Overview
5.2.3.2. Financial Information
5.2.3.3. Product Portfolio
5.2.3.4. Recent Developments and Future Outlook

5.3. Key Players Based in Europe
5.3.1. Datwyler Sealing Solutions (a Part of Datwyler Group)
5.3.1.1. Company Overview
5.3.1.2. Financial Information
5.3.1.3. Product Portfolio
5.3.1.4 Recent Developments and Future Outlook

5.3.2. Lonstroff (a Part of Sumitomo Rubber Industries)
5.3.2.1. Company Overview
5.3.2.2. Financial Information
5.3.2.2. Product Portfolio
5.3.2.3. Recent Developments and Future Outlook

5.3.3. Ompi (a Part of Stevanato Group)
5.3.3.1. Company Overview
5.3.3.2. Product Portfolio
5.3.3.3. Recent Developments and Future Outlook

5.4. Key Players Based in Asia-Pacific
5.4.1 Daikyo Seiko
5.4.1.1. Company Overview
5.4.1.2. Product Portfolio
5.4.1.3. Recent Developments and Future Outlook

5.4.2. Hebei First Rubber Medical Technology (a Part of DESHENG Group)
5.4.2.1. Company Overview
5.4.2.2. Product Portfolio
5.4.2.3. Recent Developments and Future Outlook

5.4.3. Jiangsu Hualan New Pharmaceutical Material
5.4.3.1. Company Overview
5.4.3.2. Product Portfolio
5.4.3.3. Recent Developments and Future Outlook

6. PACKAGING TRENDS ANALYSIS FOR RECENTLY APPROVED DRUGS
6.1. Chapter Overview
6.2. List of Approved Drugs (2014-2018)
6.2.1. Analysis by Year of Approval
6.2.2. Analysis by Type of Molecule
6.2.3. Analysis by Type of Biologic
6.2.4. Analysis by Holding Temperature Range
6.2.5. Analysis by Type of Container
6.2.6. Analysis by Type of Container and Year of Approval
6.2.7. Analysis by Type of Container and Type of Molecule
6.2.8. Analysis by Type of Container and Dosage Form
6.2.9. Analysis by Type of Container and Route of Administration
6.2.10. Analysis by Type of Container and Holding Temperature Range
6.2.11. Popular Type of Material Used for Containers
6.2.12. Analysis by Type of Closure
6.2.13. Analysis by Type of Closure and Year of Approval
6.2.14. Analysis by Type of Closure and Type of Molecule
6.2.15. Analysis by Type of Closure and Dosage Form
6.2.16. Analysis by Type of Closure and Route of Administration
6.2.17. Analysis by Type of Closure and Holding Temperature Range
6.2.18. Popular Type of Material Used for Closures
6.2.19. Analysis by Type of Elastomeric Material Used for Closures and Dosage Form
6.2.20. Analysis by Type of Elastomeric Material Used for Closures and Route of Administration
6.2.21. Analysis by Type of Elastomeric Material Used for Closures and Holding Temperature Range
6.2.22. Analysis by Type of Elastomeric Material Used for Closures
6.2.23. Most Active Players: Analysis by Number of Drugs Packaged Using Elastomeric Closures
6.2.24. Concluding Remarks

7. RECENT DEVELOPMENTS
7.1. Chapter Overview
7.2. Pharmaceutical Packaging Industry: Partnership Activity
7.2.1. Partnership Models
7.2.2. List of Partnerships and Collaborations
7.2.2.1. Analysis by Year of Partnership
7.2.2.2. Analysis by Type of Partnership
7.2.2.3. Analysis by Focus Area
7.2.2.4. Most Active Players: Analysis by Number of Partnerships

7.3. Elastomeric Container Closures in Pharmaceutical Packaging Industry: Recent Expansions

7.4. Pharmaceutical Packaging Industry: Recent Conferences
7.4.1. List of Recent Conferences
7.4.1.1. Analysis by Year of Occurrence
7.4.1.2. Analysis by Geography
7.4.2. Elastomeric Container Closures: List of Recent Conferences
7.4.2.1. Analysis by Focus Area / Agenda
7.4.3. Geographical Mapping of Conferences

7.5. Concluding Remarks

8. DEMAND ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Global Demand for Elastomeric Closures, 2019-2030
8.3.1. Analysis by Type of Container
8.3.1.1. Global Demand for Elastomeric Closures for Vials
8.3.1.2. Global Demand for Elastomeric Closures for Syringes
8.3.1.3. Global Demand for Elastomeric Closures for Cartridges
8.3.2. Analysis by Type of Closure
8.3.2.1. Global Demand for Elastomeric Seals
8.3.2.2. Global Demand for Elastomeric Stoppers
8.3.2.3. Global Demand for Elastomeric Caps
8.3.2.4. Global Demand for Elastomeric Plungers
8.3.2.5. Global Demand for Elastomeric Barrels
8.3.2.6. Global Demand for Elastomeric Needle Shields

8.3.3. Analysis by Sterilization Status
8.3.3.1. Global Demand for Pre-Sterilized Elastomeric Closures
8.3.3.1.1. Global Demand for Pre-Sterilized Elastomeric Seals
8.3.3.1.2. Global Demand for Pre-Sterilized Elastomeric Stoppers
8.3.3.1.3. Global Demand for Pre-Sterilized Elastomeric Caps
8.3.3.1.4. Global Demand for Pre-Sterilized Elastomeric Plungers
8.3.3.1.5. Global Demand for Pre-Sterilized Elastomeric Barrels
8.3.3.1.6. Global Demand for Pre-Sterilized Elastomeric Needle Shields

8.3.3.2. Global Demand for Unsterilized Elastomeric Closures
8.3.3.2.1. Global Demand for Unsterilized Elastomeric Seals
8.3.3.2.2. Global Demand for Unsterilized Elastomeric Stoppers
8.3.3.2.3. Global Demand for Unsterilized Elastomeric Caps
8.3.3.2.4. Global Demand for Unsterilized Elastomeric Plungers
8.3.3.2.5. Global Demand for Unsterilized Elastomeric Barrels
8.3.3.2.6. Global Demand for Unsterilized Elastomeric Needle Shields

8.3.4. Analysis by Geography
8.3.4.1. Demand for Elastomeric Closures in North America
8.3.4.1.1. Demand for Elastomeric Seals in North America
8.3.4.1.2. Demand for Elastomeric Stoppers in North America
8.3.4.1.3. Demand for Elastomeric Caps in North America
8.3.4.1.4. Demand for Elastomeric Plungers in North America
8.3.4.1.5. Demand for Elastomeric Barrels in North America
8.3.4.1.6. Demand for Elastomeric Needle Shields in North America

8.3.4.2. Demand for Elastomeric Closures in Europe
8.3.4.2.1. Demand for Elastomeric Seals in Europe
8.3.4.2.2. Demand for Elastomeric Stoppers in Europe
8.3.4.2.3. Demand for Elastomeric Caps in Europe
8.3.4.2.4. Demand for Elastomeric Plungers in Europe
8.3.4.2.5. Demand for Elastomeric Barrels in Europe
8.3.4.2.6. Demand for Elastomeric Needle Shields in Europe

8.3.4.3. Demand for Elastomeric Closures in Asia-Pacific
8.3.4.3.1. Demand for Elastomeric Seals in Asia-Pacific
8.3.4.3.2. Demand for Elastomeric Stoppers in Asia-Pacific
8.3.4.3.3. Demand for Elastomeric Caps in Asia-Pacific
8.3.4.3.4. Demand for Elastomeric Plungers in Asia-Pacific
8.3.4.3.5. Demand for Elastomeric Barrels in Asia-Pacific
8.3.4.3.6. Demand for Elastomeric Needle Shields in Asia-Pacific

8.3.4.4. Demand for Elastomeric Closures in Rest of the World
8.3.4.4.1. Demand for Elastomeric Seals in Rest of the World
8.3.4.4.2. Demand for Elastomeric Stoppers in Rest of the World
8.3.4.4.3. Demand for Elastomeric Caps in Rest of the World
8.3.4.4.4. Demand for Elastomeric Plungers in Rest of the World
8.3.4.4.5. Demand for Elastomeric Barrels in Rest of the World
8.3.4.4.6. Demand for Elastomeric Needle Shields in Rest of the World

8.4. Concluding Remarks

9. MARKET FORECAST
9.1. Chapter Overview
9.2. Forecast Methodology and Key Assumptions
9.3. Global Elastomeric Closures Market, 2019-2030
9.3.1. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Primary Container
9.3.1.1. Global Elastomeric Closures Market for Vials, 2019-2030
9.3.1.2. Global Elastomeric Closures Market for Syringes, 2019-2030
9.3.1.3. Global Elastomeric Closures Market for Cartridges, 2019-2030

9.3.2. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Closure
9.3.2.1. Global Elastomeric Closures Market for Seals, 2019-2030
9.3.2.2. Global Elastomeric Closures Market for Stoppers, 2019-2030
9.3.2.3. Global Elastomeric Closures Market for Caps, 2019-2030
9.3.2.4. Global Elastomeric Closures Market for Plungers, 2019-2030
9.3.2.5. Global Elastomeric Closures Market for Barrels, 2019-2030
9.3.2.6. Global Elastomeric Closures Market for Needle Shields, 2019-2030

9.3.3. Global Elastomeric Closures Market, 2019-2030: Distribution by Sterilization Status
9.3.3.1. Global Pre-Sterilized Elastomeric Closures Market, 2019-2030
9.3.3.1.1. Global Pre-Sterilized Elastomeric Closures Market for Seals, 2019-2030
9.3.3.1.2. Global Pre-Sterilized Elastomeric Closures Market for Stoppers, 2019-2030
9.3.3.1.3. Global Pre-Sterilized Elastomeric Closures Market for Caps, 2019-2030
9.3.3.1.4. Global Pre-Sterilized Elastomeric Closures Market for Plungers, 2019-2030
9.3.3.1.5. Global Pre-Sterilized Elastomeric Closures Market for Barrels, 2019-2030
9.3.3.1.6. Global Pre-Sterilized Elastomeric Closures Market for Needle Shields, 2019-2030

9.3.3.2. Global Unsterilized Elastomeric Closures Market, 2019-2030
9.3.3.2.1. Global Unsterilized Elastomeric Closures Market for Seals, 2019-2030
9.3.3.2.2. Global Unsterilized Elastomeric Closures Market for Stoppers, 2019-2030
9.3.3.2.3. Global Unsterilized Elastomeric Closures Market for Caps, 2019-2030
9.3.3.2.4. Global Unsterilized Elastomeric Closures Market for Plungers, 2019-2030
9.3.3.2.5. Global Unsterilized Elastomeric Closures Market for Barrels, 2019-2030
9.3.3.2.6. Global Unsterilized Elastomeric Closures Market for Needle Shields, 2019-2030

9.3.4. Global Elastomeric Closures Market, 2019-2030: Distribution by Geography
9.3.4.1. Elastomeric Closures Market in North America, 2019-2030
9.3.4.1.1. Elastomeric Closures Market for Seals in North America, 2019-2030
9.3.4.1.2. Elastomeric Closures Market for Stoppers in North America, 2019-2030
9.3.4.1.3. Elastomeric Closures Market for Caps in North America, 2019-2030
9.3.4.1.4. Elastomeric Closures Market for Plungers in North America, 2019-2030
9.3.4.1.5. Elastomeric Closures Market for Barrels in North America, 2019-2030
9.3.4.1.6. Elastomeric Closures Market for Needle Shields in North America, 2019-2030

9.3.4.2. Elastomeric Closures Market in Europe, 2019-2030
9.3.4.2.1. Elastomeric Closures Market for Seals in Europe, 2019-2030
9.3.4.2.2. Elastomeric Closures Market for Stoppers in Europe, 2019-2030
9.3.4.2.3. Elastomeric Closures Market for Caps in Europe, 2019-2030
9.3.4.2.4. Elastomeric Closures Market for Plungers in Europe, 2019-2030
9.3.4.2.5. Elastomeric Closures Market for Barrels in Europe, 2019-2030
9.3.4.2.6. Elastomeric Closures Market for Needle Shields in Europe, 2019-2030

9.3.4.3. Elastomeric Closures Market in Asia-Pacific, 2019-2030
9.3.4.3.1. Elastomeric Closures Market for Seals in Asia-Pacific, 2019-2030
9.3.4.3.2. Elastomeric Closures Market for Stoppers in Asia-Pacific, 2019-2030
9.3.4.3.3. Elastomeric Closures Market for Caps in Asia-Pacific, 2019-2030
9.3.4.3.4. Elastomeric Closures Market for Plungers in Asia-Pacific, 2019-2030
9.3.4.3.5. Elastomeric Closures Market for Barrels in Asia-Pacific, 2019-2030
9.3.4.3.6. Elastomeric Closures Market for Needle Shields in Asia-Pacific, 2019-2030

9.3.4.4. Elastomeric Closures Market in Rest of the World, 2019-2030
9.3.4.4.1. Elastomeric Closures Market for Seals in Rest of the World, 2019-2030
9.3.4.4.2. Elastomeric Closures Market for Stoppers in Rest of the World, 2019-2030
9.3.4.4.3. Elastomeric Closures Market for Caps in Rest of the World, 2019-2030
9.3.4.4.4. Elastomeric Closures Market for Plungers in Rest of the World, 2019-2030
9.3.4.4.5. Elastomeric Closures Market for Barrels in Rest of the World, 2019-2030
9.3.4.4.6. Elastomeric Closures Market for Needle Shields in Rest of the World, 2019-2030

9.4. Concluding Remarks

10. CASE STUDY: ROBOTICS IN PHARMACEUTICAL PACKAGING
10.1. Chapter Overview
10.2. Role of Robots in the Pharmaceutical Industry
10.2.1. Key Considerations for Selecting a Robotic System
10.2.2. Advantages of Robotic Systems
10.2.3. Disadvantages of Robotic Systems
10.3. Companies Providing Robots for Pharmaceutical Industry
10.4. Companies Providing Equipment Integrated with Robotic Systems for Pharmaceutical Packaging
10.4.1. Aseptic Technologies
10.4.1.1. Crystal® L1 Robot Line
10.4.1.2. Crystal® SL1 Robot Line

10.4.2. AST
10.4.2.1. ASEPTiCell® Series
10.4.2.2. ASEPTiCell® VSM-25

10.4.3. Bosch Packaging Technology
10.4.3.1. ATO

10.4.4. Dara Pharmaceutical Packaging
10.4.4.1. SYX-E CARTRIDGE + RABS

10.4.5. Fedegari Group
10.4.5.1. Fedegari Isolator

10.4.6. IMA
10.4.6.1. INJECTA
10.4.6.2. STERI LIF3

10.4.7. Steriline
10.4.7.1. Nest Filling Line RNFM

10.4.8. Vanrx Pharmasystems
10.4.8.1. Microcell Vial Filler
10.4.8.2. SA25 Aseptic Filling Workcell

11. EMERGING TRENDS IN PHARMACEUTICAL PACKAGING
11.1. Chapter Overview
11.2. Shift Towards Self-Medication using Advanced Drug Delivery Devices
11.3. Focus on Developing Improved Packaging Components and Ongoing Efforts to Optimize Manufacturing Costs
11.4. Availability of Modular Facilities
11.5. Initiatives Focused on Automation of Fill / Finish Operations
11.6. Establishment of Business Relationships Focused on Designing Compatible Packaging Materials for Various Drug Products
11.7. Increasing Activity in Developing Regions
11.8. Growing Adoption of Smart Packaging Solutions
11.9. Concluding Remarks

12. EXECUTIVE INSIGHTS
12.1. Chapter Overview
12.2. Aseptic Technologies
12.2.1. Company Snapshot
12.2.2. Interview Transcript: Julien Maréchal, Business Development and Technology Director

12.3. BioPhorum Operations Group
12.3.1. Company Snapshot
13.3.2. Interview Transcript: Malcolm Gilmore, Facilitator

12.4. Lonstroff
12.4.1. Company Snapshot
12.4.2. Interview Transcript: Marco Pederiva, Marketing and Sales Director

12.5. PYRAMID Laboratories
12.5.1. Company Snapshot
12.5.2. Interview Transcript: Konstantin Kazarian, Business Development Project Manager

13. APPENDIX 1: TABULATED DATA

14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Figures

Figure 3.1. Advantages of Pharmaceutical Packaging
Figure 3.2. Types of Pharmaceutical Packaging
Figure 3.3. Innovation in Pharmaceutical Packaging
Figure 3.4. Traditional Aseptic Pharmaceutical Filling
Figure 3.5. List of Various Primary Packaging Containers-Closures Systems
Figure 3.6. Applications of Elastomeric Materials in Various Industries
Figure 3.7. Key Properties of Elastomeric Materials
Figure 3.8. Comparison of Different Types of Packaging Materials
Figure 3.9. Advantages and Limitations of Elastomeric Materials Used in Pharmaceutical Packaging Industry
Figure 4.1. Elastomeric Closures for Parenteral Containers: Distribution by Type of Closure
Figure 4.2. Elastomeric Closures for Parenteral Containers: Distribution by Type of Container
Figure 4.3. Elastomeric Closures for Parenteral Containers: Distribution by Type of Elastomeric Material
Figure 4.4. Elastomeric Closures for Parenteral Containers: Distribution by Sterilization Status
Figure 4.5. Elastomeric Closures for Parenteral Containers: Distribution by Sterilization Technique
Figure 4.6. Elastomeric Closures for Parenteral Containers: Distribution by Type of Coating
Figure 4.7. Elastomeric Closures for Parenteral Containers: Distribution by Drug Class
Figure 4.8. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Year of Establishment
Figure 4.9. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Company Size
Figure 4.10. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Scale of Production
Figure 4.11. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Location of Headquarters
Figure 4.12. Leading Manufacturers: Distribution by Number of Products
Figure 4.13. Manufacturer Landscape: Distribution by Company Size and Location of Headquarters
Figure 5.1. AptarGroup: Annual Revenues, 2013-Q3 2018 (USD Billion)
Figure 5.2. West Pharmaceutical Services: Annual Revenues, 2013-2018 (USD Billion)
Figure 5.3. Datwyler Group: Annual Revenues, 2013-2018 (CHF Million)
Figure 5.4. Sumitomo Rubber Industries: Annual Revenues, 2013-2018 (Yen Billion)
Figure 5.5. Sumitomo Rubber Industries: Annual Revenues by Business Segments, 2018
Figure 6.1. Approved Drugs (2014-2018): Distribution by Year of Approval
Figure 6.2. Approved Drugs (2014-2018): Distribution by Type of Molecule
Figure 6.3. Approved Drugs (2014-2018): Distribution by Type of Biologic
Figure 6.4. Approved Drugs (2014-2018): Distribution by Holding Temperature Range
Figure 6.5. Approved Drugs (2014-2018): Distribution by Type of Container
Figure 6.6. Approved Drugs (2014-2018): Distribution by Type of Container and Year of Approval
Figure 6.7. Approved Drugs (2014-2018): Distribution by Type of Container and Type of Molecule
Figure 6.8. Approved Drugs (2014-2018): Distribution by Type of Container and Dosage Form
Figure 6.9. Approved Drugs (2014-2018): Distribution by Type of Container and Route of Administration
Figure 6.10. Approved Drugs (2014-2018): Distribution by Type of Container and Holding Temperature Range
Figure 6.11. Approved Drugs (2014-2018): Popular Type of Material Used for Containers in Biologics
Figure 6.12. Approved Drugs (2014-2018): Popular Type of Material Used for Containers in Small Molecule
Figure 6.13. Approved Drugs (2014-2018): Distribution by Type of Closure
Figure 6.14. Approved Drugs (2014-2018): Distribution by Type of Closure and Year of Approval
Figure 6.15. Approved Drugs (2014-2018): Distribution by Type of Closure and Type of Molecule
Figure 6.16. Approved Drugs (2014-2018): Distribution by Type of Closure and Dosage Form
Figure 6.17. Approved Drugs (2014-2018): Distribution by Type of Closure and Route of Administration
Figure 6.18. Approved Drugs (2014-2018): Distribution by Type of Closure and Holding Temperature Range
Figure 6.19. Approved Drugs (2014-2018): Popular Type of Material Used for Closures in Biologics
Figure 6.20. Approved Drugs (2014-2018): Popular Type of Material Used for Closures in Small Molecules
Figure 6.21. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Dosage Form
Figure 6.22. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Route of Administration
Figure 6.23. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Holding Temperature Range
Figure 6.24. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures
Figure 6.25. Most Active Players: Distribution by Number of Drugs Packaged using Elastomeric Closures
Figure 6.26. Approved Drugs (2014-2018), Grid Analysis: Distribution by Type of Container, Closure, Type of Material and Route of Administration
Figure 6.27. Approved Drugs (2014-2018), Bubble Analysis: Distribution by Type of Closure, Type of Elastomeric Material and Type of Molecule
Figure 7.1. Partnerships and Collaborations: Cumulative Trend by Year, Pre-2015-2019
Figure 7.2. Partnerships and Collaborations: Distribution by Type of Partnership
Figure 7.3. Partnerships and Collaborations: Distribution by Focus Area
Figure 7.4. Partnerships and Collaborations: Most Active Players
Figure 7.5. Global Conferences: Cumulative Year-Wise Trend, 2015-2019
Figure 7.6. Global Conferences: Distribution by Location
Figure 7.7. Global Conferences Related to Elastomeric Containers Closures: Key Focus Areas
Figure 7.8. Global Conferences: Geographical Mapping
Figure 8.1. Global Demand for Elastomeric Closures: Methodology and Key Assumptions
Figure 8.2. Global Demand for Elastomeric Closures, 2019-2030 (Billion Units)
Figure 8.3. Global Demand for Elastomeric Closures: Distribution by Type of Container, 2019 and 2030
Figure 8.4. Global Demand for Elastomeric Closures for Vials, 2019-2030 (Billion Units)
Figure 8.5. Global Demand for Elastomeric Closures for Syringes, 2019-2030 (Billion Units)
Figure 8.6. Global Demand for Elastomeric Closures for Cartridges, 2019-2030 (Billion Units)
Figure 8.7. Global Demand for Elastomeric Closures: Distribution by Type of Closure, 2019 and 2030
Figure 8.8. Global Demand for Elastomeric Seals, 2019-2030 (Billion Units)
Figure 8.9. Global Demand for Elastomeric Stoppers, 2019-2030 (Billion Units)
Figure 8.10. Global Demand for Elastomeric Caps, 2019-2030 (Billion Units)
Figure 8.11. Global Demand for Elastomeric Plungers, 2019-2030 (Billion Units)
Figure 8.12. Global Demand for Elastomeric Barrels, 2019-2030 (Billion Units)
Figure 8.13. Global Demand for Elastomeric Needle Shields, 2019-2030 (Billion Units)
Figure 8.14. Global Demand for Elastomeric Closures: Distribution by Sterilization Status, 2019 and 2030
Figure 8.15. Global Demand for Elastomeric Pre-Sterilized Elastomeric Closures, 2019-2030 (Billion Units)
Figure 8.16. Global Demand for Elastomeric Pre-Sterilized Elastomeric Seals, 2019-2030 (Billion Units)
Figure 8.17. Global Demand for Elastomeric Pre-Sterilized Elastomeric Stoppers, 2019-2030 (Billion Units)
Figure 8.18. Global Demand for Elastomeric Pre-Sterilized Elastomeric Caps, 2019-2030 (Billion Units)
Figure 8.19. Global Demand for Elastomeric Pre-Sterilized Elastomeric Plungers, 2019-2030 (Billion Units)
Figure 8.20. Global Demand for Elastomeric Pre-Sterilized Elastomeric Barrels, 2019-2030 (Billion Units)
Figure 8.21. Global Demand for Elastomeric Pre-Sterilized Elastomeric Needle Shields, 2019-2030 (Billion Units)
Figure 8.22. Global Demand for Elastomeric Unsterilized Elastomeric Closures, 2019-2030 (Billion Units)
Figure 8.23. Global Demand for Elastomeric Unsterilized Elastomeric Seals, 2019-2030 (Billion Units)
Figure 8.24. Global Demand for Elastomeric Unsterilized Elastomeric Stoppers, 2019-2030 (Billion Units)
Figure 8.25. Global Demand for Elastomeric Unsterilized Elastomeric Caps, 2019-2030 (Billion Units)
Figure 8.26. Global Demand for Elastomeric Unsterilized Elastomeric Plungers, 2019-2030 (Billion Units)
Figure 8.27. Global Demand for Elastomeric Unsterilized Elastomeric Barrels, 2019-2030 (Billion Units)
Figure 8.28. Global Demand for Elastomeric Unsterilized Elastomeric Needle Shields, 2019-2030 (Billion Units)
Figure 8.29. Global Demand for Elastomeric Closures: Distribution by Geography, 2019 and 2030
Figure 8.30. Demand for Elastomeric Seals in North America, 2019-2030 (Billion Units)
Figure 8.31. Demand for Elastomeric Stoppers in North America, 2019-2030 (Billion Units)
Figure 8.32. Demand for Elastomeric Caps in North America, 2019-2030 (Billion Units)
Figure 8.33. Demand for Elastomeric Plungers in North America, 2019-2030 (Billion Units)
Figure 8.34. Demand for Elastomeric Barrels in North America, 2019-2030 (Billion Units)
Figure 8.35. Demand for Elastomeric Needle Shields in North America, 2019-2030 (Billion Units)
Figure 8.36. Demand for Elastomeric Closures in Europe, 2019-2030 (Billion Units)
Figure 8.37. Demand for Elastomeric Seals in Europe, 2019-2030 (Billion Units)
Figure 8.38. Demand for Elastomeric Stoppers in Europe, 2019-2030 (Billion Units)
Figure 8.39. Demand for Elastomeric Caps in Europe, 2019-2030 (Billion Units)
Figure 8.40. Demand for Elastomeric Plungers in Europe, 2019-2030 (Billion Units)
Figure 8.41. Demand for Elastomeric Barrels in Europe, 2019-2030 (Billion Units)
Figure 8.42. Demand for Elastomeric Needle Shields in Europe, 2019-2030 (Billion Units)
Figure 8.43. Demand for Elastomeric Closures in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.44. Demand for Elastomeric Seals in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.45. Demand for Elastomeric Stoppers in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.46. Demand for Elastomeric Caps in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.47. Demand for Elastomeric Plungers in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.48. Demand for Elastomeric Barrels in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.49. Demand for Elastomeric Needle Shields in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.50. Demand for Elastomeric Closures in Rest of the World, 2019-2030 (Billion Units)
Figure 8.51. Demand for Elastomeric Seals in Rest of the World, 2019-2030 (Billion Units)
Figure 8.52. Demand for Elastomeric Stoppers in Rest of the World, 2019-2030 (Billion Units)
Figure 8.53. Demand for Elastomeric Caps in Rest of the World, 2019-2030 (Billion Units)
Figure 8.54. Demand for Elastomeric Plungers in Rest of the World, 2019-2030 (Billion Units)
Figure 8.55. Demand for Elastomeric Barrels in Rest of the World, 2019-2030 (Billion Units)
Figure 8.56. Demand for Elastomeric Needle Shields in Rest of the World, 2019-2030 (Billion Units)
Figure 9.1. Global Elastomeric Closures Market: Forecast Methodology and Key Assumptions
Figure 9.2. Global Elastomeric Closures Market, 2019-2030 (USD Billion)
Figure 9.3. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Primary Container (USD Billion)
Figure 9.4. Global Elastomeric Closures Market for Vials, 2019-2030 (USD Billion)
Figure 9.5. Global Elastomeric Closures Market for Syringes, 2019-2030 (USD Billion)
Figure 9.6. Global Elastomeric Closures Market for Cartridges, 2019-2030 (USD Billion)
Figure 9.7. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Closure (USD Billion)
Figure 9.8. Global Elastomeric Closures Market for Seals, 2019-2030 (USD Billion)
Figure 9.9. Global Elastomeric Closures Market for Stoppers, 2019-2030 (USD Billion)
Figure 9.10. Global Elastomeric Closures Market for Caps, 2019-2030 (USD Billion)
Figure 9.11. Global Elastomeric Closures Market for Plungers, 2019-2030 (USD Billion)
Figure 9.12. Global Elastomeric Closures Market for Barrels, 2019-2030 (USD Billion)
Figure 9.13. Global Elastomeric Closures Market for Needle Shields, 2019-2030 (USD Billion)
Figure 9.14. Global Elastomeric Closures Market, 2019-2030: Distribution by Sterilization Status (USD Billion)
Figure 9.15. Global Pre-Sterilized Elastomeric Closures Market, 2019-2030 (USD Billion)
Figure 9.16. Global Pre-Sterilized Elastomeric Closures Market for Seals, 2019-2030 (USD Billion)
Figure 9.17. Global Pre-Sterilized Elastomeric Closures Market for Stoppers, 2019-2030 (USD Billion)
Figure 9.18. Global Pre-Sterilized Elastomeric Closures Market for Caps, 2019-2030 (USD Billion)
Figure 9.19. Global Pre-Sterilized Elastomeric Closures Market for Plungers, 2019-2030 (USD Billion)
Figure 9.20. Global Pre-Sterilized Elastomeric Closures Market for Barrels, 2019-2030 (USD Billion)
Figure 9.21. Global Pre-Sterilized Elastomeric Closures Market for Needle Shields, 2019-2030 (USD Billion)
Figure 9.22. Global Unsterilized Elastomeric Closures Market, 2019-2030 (USD Billion)
Figure 9.23. Global Unsterilized Elastomeric Closures Market for Seals, 2019-2030 (USD Billion)
Figure 9.24. Global Unsterilized Elastomeric Closures Market for Stoppers, 2019-2030 (USD Billion)
Figure 9.25. Global Unsterilized Elastomeric Closures Market for Caps, 2019-2030 (USD Billion)
Figure 9.26. Global Unsterilized Elastomeric Closures Market for Plungers, 2019-2030 (USD Billion)
Figure 9.27. Global Unsterilized Elastomeric Closures Market for Barrels, 2019-2030 (USD Billion)
Figure 9.28. Global Unsterilized Elastomeric Closures Market for Needle Shields, 2019-2030 (USD Billion)
Figure 9.29. Elastomeric Closures Market, 2019-2030: Distribution by Geography (USD Billion)
Figure 9.30. Elastomeric Closures Market in North America, 2019-2030 (USD Billion)
Figure 9.31. Elastomeric Closures Market for Seals in North America, 2019-2030 (USD Billion)
Figure 9.32. Elastomeric Closures Market for Stoppers in North America, 2019-2030 (USD Billion)
Figure 9.33. Elastomeric Closures Market for Caps in North America, 2019-2030 (USD Billion)
Figure 9.34. Elastomeric Closures Market for Plungers in North America, 2019-2030 (USD Billion)
Figure 9.35. Elastomeric Closures Market for Barrels in North America, 2019-2030 (USD Billion)
Figure 9.36. Elastomeric Closures Market for Needle Shields in North America, 2019-2030 (USD Billion)
Figure 9.37. Elastomeric Closures Market in Europe, 2019-2030 (USD Billion)
Figure 9.38. Elastomeric Closures Market for Seals in Europe, 2019-2030 (USD Billion)
Figure 9.39. Elastomeric Closures Market for Stoppers in Europe, 2019-2030 (USD Billion)
Figure 9.40. Elastomeric Closures Market for Caps in Europe, 2019-2030 (USD Billion)
Figure 9.41. Elastomeric Closures Market for Plungers in Europe, 2019-2030 (USD Billion)
Figure 9.42. Elastomeric Closures Market for Barrels in Europe, 2019-2030 (USD Billion)
Figure 9.43. Elastomeric Closures Market for Needle Shields in Europe, 2019-2030 (USD Billion)
Figure 9.44. Elastomeric Closures Market in Asia-Pacific, 2019-2030 (USD Billion)
Figure 9.45. Elastomeric Closures Market for Seals in Asia-Pacific, 2019-2030 (USD Billion)
Figure 9.46. Elastomeric Closures Market for Stoppers in Asia-Pacific, 2019-2030 (USD Billion)
Figure 9.47. Elastomeric Closures Market for Caps in Asia-Pacific, 2019-2030 (USD Billion)
Figure 9.48. Elastomeric Closures Market for Plungers in Asia-Pacific, 2019-2030 (USD Billion)
Figure 9.49. Elastomeric Closures Market for Barrels in Asia-Pacific, 2019-2030 (USD Billion)
Figure 9.50. Elastomeric Closures Market for Needle Shields in Asia-Pacific, 2019-2030 (USD Billion)
Figure 9.51. Elastomeric Closures Market in Rest of the World, 2019-2030 (USD Billion)
Figure 9.52. Elastomeric Closures Market for Seals in Rest of the World, 2019-2030 (USD Billion)
Figure 9.53. Elastomeric Closures Market for Stoppers in Rest of the World, 2019-2030 (USD Billion)
Figure 9.54. Elastomeric Closures Market for Caps in Rest of the World, 2019-2030 (USD Billion)
Figure 9.55. Elastomeric Closures Market for Plungers in Rest of the World, 2019-2030 (USD Billion)
Figure 9.56. Elastomeric Closures Market for Barrels in Rest of the World, 2019-2030 (USD Billion)
Figure 9.57. Elastomeric Closures Market for Needle Shields in Rest of the World, 2019-2030 (USD Billion)
Figure 9.58. Overall Elastomeric Closures Market: Conservative, Base and Optimistic Scenario, 2019, 2024 and 2030 (USD Billion)
Figure 10.1. Key Considerations to Select a Robot
Figure 10.2. Advantages of Robotic Systems in Pharmaceutical Operations
Figure 11.1. Emerging Trends Related to Pharmaceutical Packaging
Figure 11.2. Future Growth Opportunities Related to Elastomeric Closures

List of Tables

Table 3.1. Key Components of Syringes
Table 3.2. Popular Types of Elastomeric Packaging Materials
Table 3.3. Popular Coatings / Surface Treatment Methods Used for Elastomeric Closures
Table 4.1. List of Elastomeric Closures for Parenteral Containers
Table 4.2. Elastomeric Closures for Parenteral Containers: Information on Type of Container
Table 4.3. Elastomeric Closures for Parenteral Containers: Information on Type of Elastomeric Material and Type of Drug Class
Table 4.4. Elastomeric Closures for Parenteral Containers: Information on Sterilization Status
Table 4.5. Elastomeric Closures for Parenteral Containers: Additional Information
Table 4.6. Elastomeric Closures for Parenteral Containers: Information on Manufacturers
Table 4.7. Elastomeric Closures for Parenteral Containers: Information on Scale of Operation of Manufacturers
Table 4.8. List of Ready-to-Use Containers-Closures Systems
Table 5.1. AptarGroup: Company Overview
Table 5.2. Aptar Pharma: Product Details
Table 5.3. AptarGroup: Recent Developments and Future Outlook
Table 5.4. DWK Life Sciences: Company Overview
Table 5.5. DWK Life Sciences: Product Details
Table 5.6. DWK Life Sciences: Recent Developments and Future Outlook
Table 5.7. West Pharmaceutical Services: Company Overview
Table 5.8. West Pharmaceutical Services: Product Details
Table 5.9. West Pharmaceutical Services: Recent Developments and Future Outlook
Table 5.10. Datwyler Sealing Solutions (a Part of Datwyler Group): Company Overview
Table 5.11. Datwyler Sealing Solutions (a Part of Datwyler Group): Product Details
Table 5.12. Datwyler Sealing Solutions (a Part of Datwyler Group) : Recent Developments and Future Outlook
Table 5.13. Lonstroff: Company Overview
Table 5.14. Sumitomo Rubber Industries: Company Overview
Table 5.15. Lonstroff: Product Details
Table 5.16. Sumitomo Rubber Industries: Recent Developments and Future Outlook
Table 5.17. Ompi (a Part of Stevanato Group): Company Overview
Table 5.18. Ompi (a Part of Stevanato Group): Product Details
Table 5.19. Ompi (a Part of Stevanato Group): Recent Developments and Future Outlook
Table 5.20. Daikyo Seiko: Company Overview
Table 5.21. Daikyo Seiko: Product Details
Table 5.22. Daikyo Seiko: Recent Developments and Future Outlook
Table 5.23. Hebei First Rubber Medical Technology: Company Overview
Table 5.24. Hebei First Rubber Medical Technology: Product Details
Table 5.25. Jiangsu Hualan New Pharmaceutical Material: Company Overview
Table 5.26. Jiangsu Hualan New Pharmaceutical Material: Product Details
Table 6.1. List of Approved Drugs (2014-2018): Information on Dosage Form, Route of Administration and Holding Temperature Range
Table 6.2. List of Approved Drugs (2014-2018): Information on Type of Container and Container Material
Table 6.3. List of Approved Drugs (2014-2018): Information on Type of Closure and Closure Material
Table 7.1. List of Partnerships and Collaborations: Information on Year and Type, 2007-2019
Table 7.2. List of Partnerships and Collaborations: Information on Focus Area and Product Type, 2007-2019
Table 7.3. List of Recent Expansions, 2014-2018
Table 7.4. Pharmaceutical Packaging Industry: List of Conferences, 2013-2019
Table 7.5. Conferences Related to Elastomeric Containers Closures: Information of Focus Area / Agenda
Table 7.6. Conferences Related to Elastomeric Containers Closures: Information on Key Speakers
Table 10.1. Pharmaceutical Robotics Manufacturers
Table 10.2. Aseptic Technologies: Company Overview
Table 10.3. Aseptic Technologies: Key Specifications of Crystal® L1 Robot Line
Table 10.4. Aseptic Technologies: Key Specifications of Crystal® SL1 Robot Line
Table 10.5. AST: Company Overview
Table 10.6. AST: Key Specifications of ASEPTiCell® Series
Table 10.7. AST: Key Specifications of ASEPTiCell® VSM-25
Table 10.8. Bosch Packaging Technology: Company Overview
Table 10.9. Bosch Packaging Technology: Key Specifications of ATO
Table 10.10. Dara Pharmaceutical Packaging: Company Overview
Table 10.11. Dara Pharmaceutical Packaging: Key Specifications of SYX-E CARTRIDGE + RABS
Table 10.12. Fedegari Group: Company Overview
Table 10.13. Fedegari Group: Key Specifications of Fedegari Isolator
Table 10.14. IMA: Company Overview
Table 10.15. IMA: Key Specifications of INJECTA
Table 10.16. IMA: Key Specifications of STERI LIF3
Table 10.17. Steriline: Company Overview
Table 10.18. Steriline: Key Specifications of Nest Filling Line RNFM
Table 10.19. Vanrx Pharmasystems: Company Overview
Table 10.20. Vanrx Pharmasystems: Key Specifications of Microcell Vial Filler
Table 10.21. Vanrx Pharmasystems: Key Specifications of SA25 Aseptic Filling Workcell
Table 12.1. Aseptic Technologies: Company Snapshot
Table 12.2. BioPhorum Operations Group: Company Snapshot
Table 12.3. Lonstroff: Company Snapshot
Table 12.4. PYRAMID Laboratories: Company Snapshot
Table 13.1. Elastomeric Closures for Parenteral Containers: Distribution by Type of Closure
Table 13.2. Elastomeric Closures for Parenteral Containers: Distribution by Type of Container
Table 13.3. Elastomeric Closures for Parenteral Containers: Distribution by Type of Elastomeric Material
Table 13.4. Elastomeric Closures for Parenteral Containers: Distribution by Sterilization Status
Table 13.5. Elastomeric Closures for Parenteral Containers: Distribution by Sterilization Technique
Table 13.6. Elastomeric Closures for Parenteral Containers: Distribution by Type of Coating
Table 13.7. Elastomeric Closures for Parenteral Containers: Distribution by Type of Drug Class
Table 13.8. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Year of Establishment
Table 13.9. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Company Size
Table 13.10. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Scale of Production
Table 13.11. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Location of Headquarters
Table 13.12. Leading Manufacturers: Distribution by Number of Products
Table 13.13. AptarGroup: Annual Revenues, 2013-Q3 2018 (USD Billion)
Table 13.14. West Pharmaceutical Services: Annual Revenues, 2013-2018 (USD Billion)
Table 13.15. Datwyler Group: Annual Revenues, 2013-2018 (CHF Million)
Table 13.16. Sumitomo Rubber Industries: Annual Revenues, 2013-2018 (Yen Billion)
Table 13.17. Sumitomo Rubber Industries: Annual Revenues by Business Segment, 2018
Table 13.18. Approved Drugs (2014-2018): Distribution by Year of Approval
Table 13.19. Approved Drugs (2014-2018): Distribution by Type of Molecule
Table 13.20. Approved Drugs (2014-2018): Distribution by Type of Biologic
Table 13.21. Approved Drugs (2014-2018): Distribution by Holding Temperature Range
Table 13.22. Approved Drugs (2014-2018): Distribution by Type of Container
Table 13.23. Approved Drugs (2014-2018): Distribution by Type of Container and Year of Approval
Table 13.24. Approved Drugs (2014-2018): Distribution by Type of Container and Type of Molecule
Table 13.25. Approved Drugs (2014-2018): Distribution by Type of Container and Dosage Form
Table 13.26. Approved Drugs (2014-2018): Distribution by Type of Container and Route of Administration
Table 13.27. Approved Drugs (2014-2018): Distribution by Type of Container and Holding Temperature Range
Table 13.28. Approved Drugs (2014-2018): Popular Type of Material Used for Containers in Biologics
Table 13.29. Approved Drugs (2014-2018): Popular Type of Material Used for Containers in Small Molecule
Table 13.30. Approved Drugs (2014-2018): Distribution by Type of Closure
Table 13.31. Approved Drugs (2014-2018): Distribution by Type of Closure and Year of Approval
Table 13.32. Approved Drugs (2014-2018): Distribution by Type of Closure and Type of Molecule
Table 13.33. Approved Drugs (2014-2018): Distribution by Type of Closure and Dosage Form
Table 13.34. Approved Drugs (2014-2018): Distribution by Type of Closure and Route of Administration
Table 13.35. Approved Drugs (2014-2018): Distribution by Type of Closure and Holding Temperature Range
Table 13.36. Approved Drugs (2014-2018): Popular Type of Material Used for Closures in Biologics
Table 13.37. Approved Drugs (2014-2018): Popular Type of Material Used for Closures in Small Molecules
Table 13.38. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Dosage Form
Table 13.39. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Route of Administration
Table 13.40. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Holding Temperature Range
Table 13.41. Approved Drugs (2014-2018): Distribution by Types of Elastomeric Material Used for Closures
Table 13.42. Most Active Players: Distribution by Number of Drugs Packaged Using Elastomeric Closures
Table 13.43. Partnerships and Collaborations: Cumulative Trend by Year, Pre-2015-2019
Table 13.44. Partnerships and Collaborations: Distribution by Type of Partnership
Table 13.45. Partnerships and Collaborations: Distribution by Focus Area
Table 13.46. Partnerships and Collaborations: Most Active Players
Table 13.47. Global Conferences: Cumulative Year-Wise Trend, 2015-2019
Table 13.48. Global Conferences: Distribution by Location
Table 13.49. Global Demand for Elastomeric Closures, 2019-2030 (Billion Units)
Table 13.50. Global Demand for Elastomeric Closures: Distribution by Type of Container, 2019 and 2030
Table 13.51. Global Demand for Elastomeric Closures for Vials, 2019-2030 (Billion Units)
Table 13.52. Global Demand for Elastomeric Closures for Syringes, 2019-2030 (Billion Units)
Table 13.53. Global Demand for Elastomeric Closures for Cartridges, 2019-2030 (Billion Units)
Table 13.54. Global Demand for Elastomeric Closures: Distribution by Type of Closure, 2019 and 2030
Table 13.55. Global Demand for Elastomeric Seals, 2019-2030 (Billion Units)
Table 13.56. Global Demand for Elastomeric Stoppers, 2019-2030 (Billion Units)
Table 13.57. Global Demand for Elastomeric Caps, 2019-2030 (Billion Units)
Table 13.58. Global Demand for Elastomeric Plungers, 2019-2030 (Billion Units)
Table 13.59. Global Demand for Elastomeric Barrels, 2019-2030 (Billion Units)
Table 13.60. Global Demand for Elastomeric Needle Shields, 2019-2030 (Billion Units)
Table 13.61. Global Demand for Elastomeric Closures: Distribution by Sterilization Status, 2019 and 2030
Table 13.62. Global Demand for Elastomeric Pre-Sterilized Elastomeric Closures, 2019-2030 (Billion Units)
Table 13.63. Global Demand for Elastomeric Pre-Sterilized Elastomeric Seals, 2019-2030 (Billion Units)
Table 13.64. Global Demand for Elastomeric Pre-Sterilized Elastomeric Stoppers, 2019-2030 (Billion Units)
Table 13.65. Global Demand for Elastomeric Pre-Sterilized Elastomeric Caps, 2019-2030 (Billion Units)
Table 13.66. Global Demand for Elastomeric Pre-Sterilized Elastomeric Plungers, 2019-2030 (Billion Units)
Table 13.67. Global Demand for Elastomeric Pre-Sterilized Elastomeric Barrels, 2019-2030 (Billion Units)
Table 13.68. Global Demand for Elastomeric Pre-Sterilized Elastomeric Needle Shields, 2019-2030 (Billion Units)
Table 13.69. Global Demand for Elastomeric Unsterilized Elastomeric Closures, 2019-2030 (Billion Units)
Table 13.70. Global Demand for Elastomeric Unsterilized Elastomeric Seals, 2019-2030 (Billion Units)
Table 13.71. Global Demand for Elastomeric Unsterilized Elastomeric Stoppers, 2019-2030 (Billion Units)
Table 13.72. Global Demand for Elastomeric Unsterilized Elastomeric Caps, 2019-2030 (Billion Units)
Table 13.73. Global Demand for Elastomeric Unsterilized Elastomeric Plungers, 2019-2030 (Billion Units)
Table 13.74. Global Demand for Elastomeric Unsterilized Elastomeric Barrels, 2019-2030 (Billion Units)
Table 13.75. Global Demand for Elastomeric Unsterilized Elastomeric Needle Shields, 2019-2030 (Billion Units)
Table 13.76. Global Demand for Elastomeric Closures: Distribution by Geography, 2019 and 2030
Table 13.77. Demand for Elastomeric Seals in North America, 2019-2030 (Billion Units)
Table 13.78. Demand for Elastomeric Stoppers in North America, 2019-2030 (Billion Units)
Table 13.79. Demand for Elastomeric Caps in North America, 2019-2030 (Billion Units)
Table 13.80. Demand for Elastomeric Plungers in North America, 2019-2030 (Billion Units)
Table 13.81. Demand for Elastomeric Barrels in North America, 2019-2030 (Billion Units)
Table 13.82. Demand for Elastomeric Needle Shields in North America, 2019-2030 (Billion Units)
Table 13.83. Demand for Elastomeric Closures in Europe, 2019-2030 (Billion Units)
Table 13.84. Demand for Elastomeric Seals in Europe, 2019-2030 (Billion Units)
Table 13.85. Demand for Elastomeric Stoppers in Europe, 2019-2030 (Billion Units)
Table 13.86. Demand for Elastomeric Caps in Europe, 2019-2030 (Billion Units)
Table 13.87. Demand for Elastomeric Plungers in Europe, 2019-2030 (Billion Units)
Table 13.88. Demand for Elastomeric Barrels in Europe, 2019-2030 (Billion Units)
Table 13.89. Demand for Elastomeric Needle Shields in Europe, 2019-2030 (Billion Units)
Table 13.90. Demand for Elastomeric Closures in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.91. Demand for Elastomeric Seals in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.92. Demand for Elastomeric Stoppers in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.93. Demand for Elastomeric Caps in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.94. Demand for Elastomeric Plungers in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.95. Demand for Elastomeric Barrels in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.96. Demand for Elastomeric Needle Shields in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.97. Demand for Elastomeric Closures in Rest of the World, 2019-2030 (Billion Units)
Table 13.98. Demand for Elastomeric Seals in Rest of the World, 2019-2030 (Billion Units)
Table 13.99. Demand for Elastomeric Stoppers in Rest of the World, 2019-2030 (Billion Units)
Table 13.100. Demand for Elastomeric Caps in Rest of the World, 2019-2030 (Billion Units)
Table 13.101. Demand for Elastomeric Plungers in Rest of the World, 2019-2030 (Billion Units)
Table 13.102. Demand for Elastomeric Barrels in Rest of the World, 2019-2030 (Billion Units)
Table 13.103. Demand for Elastomeric Needle Shields in Rest of the World, 2019-2030 (Billion Units)
Table 13.104. Global Elastomeric Closures Market, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.105. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Primary Container (USD Billion)
Table 13.106. Global Elastomeric Closures Market for Vials, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.107. Global Elastomeric Closures Market for Syringes, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.108. Global Elastomeric Closures Market for Cartridges, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.109. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Closure (USD Billion)
Table 13.110. Global Elastomeric Closures Market for Seals, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.111. Global Elastomeric Closures Market for Stoppers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.112. Global Elastomeric Closures Market for Caps, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.113. Global Elastomeric Closures Market for Plungers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.114. Global Elastomeric Closures Market for Barrels, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.115. Global Elastomeric Closures Market for Needle Shields, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.116. Global Elastomeric Closures Market, 2019-2030: Distribution by Sterilization Status (USD Billion)
Table 13.117. Global Pre-Sterilized Elastomeric Closures Market, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.118. Global Pre-Sterilized Elastomeric Closures Market for Seals, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.119. Global Pre-Sterilized Elastomeric Closures Market for Stoppers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.120. Global Pre-Sterilized Elastomeric Closures Market for Caps, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.121. Global Pre-Sterilized Elastomeric Closures Market for Plungers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.122. Global Pre-Sterilized Elastomeric Closures Market for Barrels, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.123. Global Pre-Sterilized Elastomeric Closures Market for Needle Shields, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.124. Global Unsterilized Elastomeric Closures Market, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.125. Global Unsterilized Elastomeric Closures Market for Seals, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.126. Global Unsterilized Elastomeric Closures Market for Stoppers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.127. Global Unsterilized Elastomeric Closures Market for Caps, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.128. Global Unsterilized Elastomeric Closures Market for Plungers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.129. Global Unsterilized Elastomeric Closures Market for Barrels, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.130. Global Unsterilized Elastomeric Closures Market for Needle Shields, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.131. Global Elastomeric Closures Market, 2019-2030: Distribution by Geography (USD Billion)
Table 13.132. Elastomeric Closures Market in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.133. Elastomeric Closures Market for Seals in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.134. Elastomeric Closures Market for Stoppers in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.135. Elastomeric Closures Market for Caps in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.136. Elastomeric Closures Market for Plungers in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.137. Elastomeric Closures Market for Barrels in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.138. Elastomeric Closures Market for Needle Shields in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.139. Elastomeric Closures Market in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.140. Elastomeric Closures Market for Seals in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.141. Elastomeric Closures Market for Stoppers in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.142. Elastomeric Closures Market for Caps in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.143. Elastomeric Closures Market for Plungers in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.144. Elastomeric Closures Market for Barrels in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.145. Elastomeric Closures Market for Needle Shields in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.146. Elastomeric Closures Market in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.147. Elastomeric Closures Market for Seals in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.148. Elastomeric Closures Market for Stoppers in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.149. Elastomeric Closures Market for Caps in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.150. Elastomeric Closures Market for Plungers in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.151. Elastomeric Closures Market for Barrels in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.152. Elastomeric Closures Market for Needle Shields in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.153. Elastomeric Closures Market in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.154. Elastomeric Closures Market for Seals in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.155. Elastomeric Closures Market for Stoppers in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.156. Elastomeric Closures Market for Caps in Rest of the World, 2019-2030 (USD Billion)
Table 13.157. Elastomeric Closures Market for Plungers in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.158. Elastomeric Closures Market for Barrels in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.159. Elastomeric Closures Market for Needle Shields in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)

List of Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report.

  1. ABB
  2. AbbVie
  3. Abu Dhabi Polytechnic 
  4. ACADIA Pharmaceuticals
  5. Accurate Elastomer Products
  6. AcelRx Pharmaceuticals
  7. Achaogen
  8. Acme Vial and Glass
  9. Acorda Therapeutics
  10. Actelion Pharmaceuticals
  11. Advanced Accelerator Applications
  12. AdvantaPure
  13. Aerie Pharmaceuticals
  14. Afton Scientific
  15. Agios Pharmaceuticals
  16. AkaRx
  17. Akcea Therapeutics
  18. Alcon Laboratories
  19. Alexion Pharmaceuticals
  20. Alkermes
  21. Allergan
  22. Allergy Laboratories
  23. Almirall
  24. Amcor
  25. Amgen
  26. Amphastar Pharmaceuticals
  27. Anacor Pharmaceuticals
  28. Anhui Huafeng Pharmaceutical Rubber
  29. Anhui Zhongma Rubber & Plastic Products
  30. Antares Pharma
  31. APG Europe
  32. API Pharma
  33. Aptar CSP Technologies
  34. Aptar Pharma
  35. Aquestive Therapeutics
  36. ARaymond Life
  37. Ariad Pharmaceuticals
  38. ARLANXEO
  39. Array BioPharma
  40. Aseptic Technologies 
  41. Assem-Pak
  42. Astellas Pharma
  43. AstraZeneca
  44. Automated Systems of Tacoma (AST)
  45. Balda Group (part of Stevanato Group)
  46. Bausch & Lomb
  47. Bausch Health
  48. Bayer 
  49. Becton Dickinson
  50. Berry Global
  51. Bespak 
  52. Bharat Rubber Works
  53. BioCryst Pharmaceuticals
  54. Biogen
  55. BioMarin Pharmaceutical
  56. BioPhorum Operations Group
  57. Black Frame Advisors
  58. BloodWorks Northwest
  59. Blue Earth
  60. Boehringer Ingelheim
  61. Bosch Packaging Technology
  62. Bracco Diagnostics
  63. Bright Indotech
  64. Bristol-Myers Squibb (BMS)
  65. BV Holdings
  66. C Otto Gehrckens
  67. Caps and Seals
  68. Catalyst Pharmaceuticals 
  69. Celgene
  70. Celltrion 
  71. Chelsea Therapeutics
  72. Chemo Research
  73. Chiesi USA
  74. Ciron Drugs
  75. Cixi Lixin Rubber 
  76. Cleveland Cord Blood Center
  77. Clovis Oncology
  78. Cole-Parmer
  79. Columbia Engineered Rubber
  80. Corning
  81. Cosmo Pharmaceuticals
  82. CSPC Pharmaceutical Group
  83. Cubist Pharmaceuticals
  84. Daiichi Sankyo
  85. Daikyo Seiko
  86. Danyang Jincheng Medical Rubber & Plastics
  87. Dara Pharmaceutical Packaging
  88. Datwyler Sealing Solutions 
  89. Dayou Trading
  90. Debiotech
  91. DENSO 
  92. Dow Corning 
  93. DowDuPont Specialty Products (DuPont) Division
  94. DSM Hydrocolloids
  95. Duke University School of Medicine
  96. Duran Group
  97. Durata Therapeutics
  98. DWK Life Sciences
  99. Eastman Chemical
  100. Eisai
  101. Eli Lilly
  102. Elusys Therapeutics
  103. EMA Pharmaceuticals
  104. EMD Serono
  105. Enable Injections
  106. ExxonMobil Chemical
  107. EyePoint Pharmaceuticals
  108. FANUC America
  109. Fedegari Group
  110. Ferrer
  111. Fibrocell Technologies
  112. Fresenius Kabi
  113. GCL Pharma
  114.     GE Healthcare Life Sciences
  115. Genentech
  116. German Institute of Rubber Technology (DIK)
  117. Gerresheimer
  118. Gilead Sciences
  119. GlaxoSmithKline
  120. Greenwich Biosciences
  121. H K Zion Industry
  122. HealthPrize Technologies 
  123. Hebei First Rubber Medical Technology
  124. Helsinn Healthcare
  125. Henan Zhengzhou Songshan Enterprise Group
  126. Hubei Huaqiang High-Tech 
  127. Hunan Runfuture Pharmatech
  128. Industria Macchine Automatiche (IMA) 
  129. Infinity Pharmaceuticals
  130. Insmed
  131. Insulet
  132. Intercept Pharmaceuticals
  133. Ionis Pharmaceuticals
  134. IPM Technologies 
  135. Ironwood Pharmaceuticals
  136. ITF Pharma
  137. Jain Rubbers
  138. Jamnadas Industries
  139. Janssen
  140. Jazz Pharmaceuticals
  141. Jiangsu Best New Medical Material 
  142. Jiangsu Hualan New Pharmaceutical Material
  143. Jiangyin Aisun Import & Export 
  144. Jiangyin Chengfeng Rubber and Plastic
  145. Jiangyin Hongmeng Rubber Plastic Product 
  146. Jiangyin Tejie Rubber & Plastic
  147. Jiangyin Yonghong Rubber
  148. Jinan Youlyy Industrial
  149. JOTOP GLASS
  150. KAI Pharmaceuticals
  151. Kali Care
  152. Kawasaki Heavy Industries
  153. Kimble Chase
  154. Kite Pharma
  155. Kraton
  156. KUKA 
  157. Kwality Pharma Rubber Industries
  158. KWK Kremsmünster
  159. Kyoraku
  160. KYTHERA Biopharmaceuticals
  161. La Jolla Pharmaceutical Company
  162. Lanxess
  163. Leadiant Biosciences
  164. Leibniz Association
  165. Lexicon Pharmaceuticals
  166. LifeSouth Community Blood Centers
  167. Lonstroff
  168. Loxo Oncology
  169. Lupin
  170. Malaysian Rubber Board
  171. Marchesini Group
  172. Massman Automation Designs
  173. Mayne Pharma 
  174. Medicines Development for Global Health
  175. Megaplast
  176. Melinta Therapeutics
  177. Merck
  178. Millennium Pharmaceuticals
  179. Millipore Sigma
  180. Mitsubishi Tanabe Pharma
  181. MJS Packaging
  182. Momentive
  183. Motiba Silicone
  184. Mylan
  185. Naniwa Rubber
  186. National University of Ireland, Galway
  187. Neelam Global
  188. Neurocrine Biosciences
  189. Neutral Glass and Allied Industries
  190. New York Blood Center
  191. NextPharma Technologies
  192. Ningbo Xingya Rubber & Plastic
  193. Ningbo Zhengli Pharmaceutical Packing
  194. Nipro PharmaPackaging
  195. Noble International
  196. Nordson EFD
  197. Novartis
  198. Novimmune
  199. Novio
  200. Novo Nordisk
  201. NPS Pharmaceuticals
  202. Ocular Therapeutics
  203. Ohio State University
  204. Ompi (part of Stevanato Group)
  205. OMRON Industrial Automation
  206. Organogenesis
  207. Organon International
  208. Ortho Dermatologics
  209. Otsuka Pharmaceutical
  210. Ott
  211. Pack Source
  212. Paladin Labs
  213. Pall Biotech
  214. Pall Life Sciences
  215. Paratek Pharmaceuticals
  216. Pfizer
  217. PharMediPack Direkt
  218. Piramal Imaging
  219. Plas-Tech Engineering
  220. PolyOne
  221. Polytec Industries
  222. Portola Pharmaceuticals
  223. Prince Rubber & Plastics 
  224. Prince Sterilization Services
  225. Propeller Health
  226. Prysmian Group
  227. PTC Therapeutics
  228. Puma Biotechnology
  229. Puyang Lumeng Glass Product
  230. PYRAMID Laboratories 
  231. Qindao Huaren Medical
  232. Qure Medical
  233. Radius Health
  234. RAUMEDIC
  235. Regeneron Pharmaceuticals
  236. Relypsa
  237. Rempex Pharmaceuticals
  238. Retrophin 
  239. Rigel Pharmaceuticals
  240. Rizhao Donggang Mtntai Industry and Trade
  241. Roche
  242. RubberMill
  243. Sagar Rubber Products
  244. Samsung Medical Rubber
  245. Sanofi
  246. Sanofi Genzyme 
  247. Sarepta Therapeutics
  248. SCHOTT
  249. SCHOTT-KAISHA
  250. Seiko Epson
  251. Servier 
  252. Shady Pack
  253. Shandong Pharmaceutical Glass
  254. Sheng Zou Rubber & Plastics
  255. Shenzhen Fushiyuan Rubber and Plastic Factory
  256. Shionogi
  257. Shire Pharmaceuticals
  258. Shreenidhi Rubber
  259. SHRIJI Rubber Industries
  260. Shrinath Products (a division of Elmer Products)
  261. Shyam Well Pack Industries
  262. SIGA Technologies
  263. SIGMA Plastic Services
  264. SKAN
  265. Sonata Rubber
  266. Spark Therapeutics
  267. Spectrum Pharmaceuticals
  268. Splendid Industry
  269. Sprout Pharmaceuticals
  270. SSM Health Cardinal Glennon Children's Hospital 
  271. Staubli
  272. Stemline Therapeutics
  273. Steriline
  274. Stock Cap
  275. Strongbridge Biopharma
  276. Sumitomo Rubber Industries
  277. Sun Pharmaceutical Industries 
  278. SureCare
  279. SVM Automatik 
  280. Synergy Pharmaceuticals
  281. Taizhou Kanglong Pharmaceutical Packing
  282. Taiho Oncology
  283. TaiMed Biologics
  284. Taiwan Ta Sheh Heng Yi Enterprise Group
  285. Takeda Pharmaceuticals
  286. Tekpak
  287. TESARO
  288. Tetraphase Pharmaceuticals
  289. Teva Pharmaceutical Industries
  290. Teva Respiratory (part of Teva Pharmaceutical Industries)
  291. The Medicines Company
  292. The Plasticoid Company
  293. TherapeuticsMD
  294. Theravance Biopharma 
  295. Tip-Top
  296. Tohoku University
  297. Triveni Polymers
  298. Tyndall National Institute 
  299. UD Pharma Rubber Products
  300. Ultragenyx Pharmaceutical
  301. Union Chimique Belge
  302. United Scientific Supplies
  303. United Therapeutics
  304. Universal Medicap
  305. Universal Robots
  306. University of Colorado Cord Blood Bank
  307. Urologix
  308. US WorldMeds
  309. Valeant Pharmaceuticals
  310. Vanda Pharmaceuticals
  311. Vanrx Pharmasystems
  312. Verastem Oncology
  313. Vericel
  314. Vertex Pharmaceuticals
  315. Verux
  316. Vighnesh Rubbers
  317. Viscon Rubber
  318. VitaMed
  319. Vital Parts
  320. VWR (a part of Avantor)
  321. Weidmann Medical Technology
  322. Wellstat Therapeutics
  323. West Pharmaceutical Services
  324. Wheaton Industries
  325. Wyeth
  326. Xiamen Petrel Rubber & Plastic Products
  327. Yangjiang Jinbi Rubber Products
  328. Yangzhong Wealth Metal
  329. Yantai Xinhui Packing
  330. Yaskawa Electric
  331. Yichang Huaqiang Trade 
  332. Zhengzhou Aoxiang Pharmaceutical Packing
  333. Zibo Dongda Medical Rubber

PRICING DETAILS

USD 4,499

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com

This site uses cookies for better browsing experience  Accept

Copyright © 2023 Roots Analysis. All Rights Reserved.